Trial intelligence / Profile preview

Bio-Oss Graft for Bone Support After 3rd Molar Extraction

NCT02753439Unknown

Sponsor
Tzafon Medical Center
Start
Feb 2017
Primary completion
Feb 2018
Modality
Device-based Delivery
01

Overview

Randomised, open-label trial of deproteinized bovine bone in impacted third molar (I3M) (2 arms), sponsored by Tzafon Medical Center. Primary endpoints: Tooth Mobility at 6 months and Periodontal Pocket Depth at 6 months. Status: unknown.

02

Drugs

deproteinized bovine bone
03

Conditions

impacted third molar (I3M)

Beyond the preview

Go deeper on NCT02753439.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02753439.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call